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Abstract
Background: Providing sexual health services in primary care is an essential step towards universal provision.
However they are not offered consistently. We conducted a national pilot of an educational intervention to
improve staff’s skills and confidence to increase chlamydia testing rates and provide condoms with contraceptive
information plus HIV testing according to national guidelines, known as 3Cs&HIV. The effectiveness of the pilot on
chlamydia testing and diagnosis rates in general practice was evaluated.
Methods: The pilot was implemented using a step-wedge design over three phases during 2013 and 2014 in
England. The intervention combined educational workshops with posters, testing performance feedback and
continuous support. Chlamydia testing and diagnosis rates in participating general practices during the control and
intervention periods were compared adjusting for seasonal trends in chlamydia testing and differences in practice
size. Intervention effect modification was assessed for the following general practice characteristics: chlamydia
testing rate compared to national median, number of general practice staff employed, payment for chlamydia
screening, practice urban/rurality classification, and proximity to sexual health clinics.
Results: The 460 participating practices conducted 26,021 tests in the control period and 18,797 tests during the
intervention period. Intention-to-treat analysis showed no change in the unadjusted median tests and diagnoses per
month per practice after receiving training: 2.7 vs 2.7; 0.1 vs 0.1. Multivariable negative binomial regression analysis
found no significant change in overall testing or diagnoses post-intervention (incidence rate ratio (IRR) 1.01, 95 %
confidence interval (CI) 0.96–1.07, P = 0.72; 0.98 CI 0.84–1.15, P = 0.84, respectively). Stratified analysis showed testing
increased significantly in practices where payments were in place prior to the intervention (IRR 2.12 CI 1.41–3.18, P < 0.
001) and in practices with 6–15 staff (6–10 GPs IRR 1.35 (1.07–1.71), P = 0.012; 11–15 GPs IRR 1.37 (1.09–1.73), P = 0.007).
Conclusion: This national pilot of short educational training sessions found no overall effect on chlamydia testing in
primary care. However, in certain sub-groups chlamydia testing rates increased due to the intervention. This demonstrates
the importance of piloting and evaluating any service improvement intervention to assess the impact before widespread
implementation, and the need for detailed understanding of local services in order to select effective interventions.
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Step-wedge, Implementation
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Background
In England, diagnoses of sexually transmitted infections
(STIs) are increasing. Young adults aged 16–25 continue
to be at the highest risk of contracting an STI. Chlamydia,
which can cause pelvic inflammatory disease and infertil-
ity, is the most commonly diagnosed infection in this age
group with over 200,000 diagnoses made in 2013 and
2014 [1, 2]. Sexual health services have traditionally been
provided in specialist services including genitourinary
medicine clinics (GUM). However general practice has
been identified by successive UK governments and
national public health bodies as an important facilitator in
the provision of sexual health services through increased
testing, partner follow up and prevention [3, 4]. An
estimated 303.9 million primary care consultations occur
every year [5], and almost 75 % of young people attend
their general practice annually [6]. General practice is an
accessible and acceptable setting for patients’ to receive
sexual health services [3, 4, 6–13] and the English national
guidelines recommend general practices provide chla-
mydia tests to all sexually active <25 year olds [14].
Despite this, sexual health services are not universally
offered in general practices, leaving missed opportunities
to diagnose infections and provide contraceptives [15, 16].
A lack of education and training for all general practice
staff, including nurses and receptionists, contribute to this
shortfall in service [17, 18]. Complex multifaceted
interventions to improve sexual health service provision
in primary care have successfully improved the skills,
confidence and motivation of practice staff to offer sexual
health services to patients. These interventions consist of
components including educational training sessions,
promotional material, automated reminders, specific pay-
ments for chlamydia testing and testing rate feedback
[19–28]. However, success has varied and these interven-
tions may not work outside of trial conditions. Differences
between a research setting and practical implementation
may relate to funding, enthusiasm for the intervention
and changes to policies and responsibilities for service
delivery [29]. Therefore, there is a need to pilot and
further evaluate interventions when translating research
into practice.
The Chlamydia Intervention Randomised Trial (CIRT)
increased chlamydia testing in general practices that
received the intervention [19]. The CIRT intervention
combined educational workshops with posters, testing
performance feedback and on-going support from a
researcher to significantly increase chlamydia testing
rates in practices receiving the intervention. Public
Health England (PHE) has expanded and piloted this
intervention to incorporate policy changes since CIRT,
such as the integration of chlamydia testing with other
sexual and reproductive services. The expanded inter-
vention (3Cs&HIV) encouraged general practice staff to
routinely offer chlamydia testing, and provide informa-
tion about the provision of contraceptive services and
free condoms (the ‘3Cs’) to all 15–24 year olds regard-
less of the type of consultation, and offer HIV testing
according to national guidelines. The aim of the pilot
was to determine the feasibility of implementing this
intervention outside of trial conditions with existing
local authority funded staff. This paper presents part of
the results of the service evaluation of this pilot, specific-
ally the primary outcome of chlamydia testing and diag-
nostic rate changes in participating general practices.
HIV testing rates and contraceptive advice provision will
be evaluated separately. Process evaluation measures
assessing uptake of the intervention are also presented.
Methods
Study design
The pilot protocol details the full methodology of this
service evaluation including sample size determination
and inclusion/exclusion criteria [30]. All local authorities
(LAs) in England were invited to participate and provide
nominated trainers. Trainers recruited general practices
and delivered the two training sessions: the first on
chlamydia, contraception and condoms and the second
on HIV. All general practices in each participating LA
were offered training and those that accepted were
randomly allocated to receive the first training session in
one of three phases as part of the step-wedge design of
the pilot. These started in August 2013, November 2013
and February 2014. The step-wedge design allowed
trainers to stagger the educational sessions while still
enabling seasonal variations in chlamydia testing to be
accounted for in the analysis [31]. If necessary, practices
could choose to receive the training in a different phase.
Practices could also choose to take part after training
had already begun in other practices. Data on general
practice recruitment, retention and uptake of the two
training sessions were collected throughout the pilot by
trainers. Feedback from participants on the training was
collected using a standardised questionnaire directly
after each session. Results for the 3Cs training session
are presented here.
Data sources and study outcome
Practice specific chlamydia testing and diagnosis data for
patients aged 15–24 from January 2013 to September 2014
were extracted from the national chlamydia surveillance
system, the Chlamydia Testing Activity Dataset (CTAD) to
calculate crude chlamydia testing and diagnosis rates for
the control and intervention periods. This time period di-
verts from the original protocol, which specified using data
from February 2012 to July 2015, due to incomplete CTAD
data for 2012 and October 2014 to July 2015. A follow up
analysis of the longer term effect of the intervention will
Town et al. BMC Public Health  (2016) 16:686 Page 2 of 9
include data up to July 2015, when complete data is
available. These data, combined with descriptive informa-
tion on the practices, were used to assess changes in
absolute and relative testing and chlamydia diagnosis rates
per 100 registered 15–24 year old patients within each
participating practice pre-intervention (control) and inter-
vention periods.
Statistical analysis
Multivariable negative binomial regression models with
general practice fitted as a random effect were used to
estimate incident rate ratios (IRR) comparing testing and
diagnosis rates pre- and post-training. Analyses were
repeated using data for all practices that initially agreed to
participate in the pilot (intention-to-treat (ITT)) [32] and
using data for practices that received at least one training
session (per-protocol (PP)) (Fig. 1). For the ITT and PP
analysis, the intervention period began in the month the
practice received training. For the ITT analysis only, the
intervention period for the practices that agreed to partici-
pate but did not receive training, was defined as the first
month of the phase the practice was allocated. Due to the
step-wedge design, the number of months contributing to
the control and intervention periods differed depending
on which phase the general practice was allocated to and
when the practice received training (Fig. 2). ITT and PP
analyses were performed on all study patients, and for
men and women separately. Month of test and practice
population size were included as fixed effects in the model
to adjust for seasonal trends in chlamydia testing and
differences in practice size.
To assess effect modification the following interaction
terms were included in the model using a forward step-
wise approach and likelihood ratio test to decide if they
should remain in this model: historical practice chlamydia
testing rate per 100 15–24 year old registered population
compared to national median per practice (2.6 tests per 100
patients registered); practice specific indices of multiple
deprivation (IMD) (a weighted measure of deprivation
using a combination of 38 separate indicators) [33]; number
of general practitioners (GPs) employed per practice, num-
ber of nurses employed per practice; whether the practice is
paid specifically for chlamydia testing before receiving
training; practice urban/rurality classification; GUM clinic
proximity to practice; phase of implementation and practice
LA. Two additional variables were included in the PP
models to assess fidelity: the number of GPs and nurses
who attended the first training session.
All analyses were carried out using STATA v13.
Results
Process evaluation: uptake of intervention
One third of English LAs (49/152) chose to participate
in the 3Cs&HIV pilot offering training to 29 % (2,343/
8,038) of general practices in England. Of these
practices, 20 % (460/2,343) agreed to participate with
512,567 patients aged 15–24 years registered. Overall
58 % (268/460) of practices that agreed to participate
received at least one training session. However, only
25 % (113/460) received both the 3Cs and HIV sessions.
Of those that received training, 68 % (183/268) were
randomised to a phase. The remaining third were not
randomised to phase as they chose to participate after
the initial recruitment process. Of those that were ran-
domly allocated to a phase, 67 % (124/183) received
training in the phase allocated. Six LAs did not imple-
ment training; for one LA, no practices agreed to partici-
pate, three LAs had staffing problems and two LAs did
not provide data about implementation; as a result 58
practices who agreed to participate were excluded in the
per-protocol analysis along with a further 134 practices
that did not receive training despite agreeing to partici-
pate. Figure 1 outlines recruitment and retention of LAs
and general practices.
The practices that received training (per-protocol) were
broadly similar to all recruited practices (intention-to-
treat) (Table 1). Similar proportions of GPs and nurses
attended training (GPs 36 %; 863/2367: nurses 40 %; 808/
2011). However, when compared to the total number of
GPs or nurses employed by the practice, a higher propor-
tion of nurses attended training.
Participant feedback on training
Feedback scores were available from 1,156 evaluations
forms from 121/267 3Cs training sessions. Not all trainers
were able to collect feedback from all sessions because not
all staff completed the questionnaire. All mean scores
were above 4/5 (Fig. 3). Trainer’s knowledge and useful-
ness of the presentation scored highest (4.7 and 4.6,
respectively). Participants also scored a mean of 4.4 for
“How likely are you to increase your chlamydia testing as
a result of this training”. The question on the usefulness of
short educational videos scored lowest. Evaluation forms
highlighted that there were difficulties viewing these vid-
eos in the practice setting due to the equipment available.
Regression analysis
Within all 460 practices recruited, during the pre-
intervention period (control) there were 26,021 chlamydia
tests completed and 18,797 in the post-intervention period.
The median testing rate per practice per month was 2.7 in
both the control and intervention period. In the control
period 1,493 chlamydia infections were detected compared
with 955 in the intervention period. The median chlamydia
diagnosis rate per practice per month being 0.1 in both
control intervention period. Figure 4 outlines the un-
adjusted median tests per month from January 2013 to
September 2014 for practices allocated to each phase of
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included in the per-protocol analysis 
included in the intention-to-treat analysis 
Fig. 1 Uptake of 3Cs&HIV training by general practices across local authorities (LAs) in England
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the pilot. Median tests fluctuated between 1 and 3 tests per
month for all practices that received training (or were
allocated to receive training) in phase 1, 2 or 3. Practices
that received training after phase 3 (between May 2014
and September 2014) did more tests per month, fluctuating
between 2 and 5 tests.
After adjusting for variables associated with chlamydia
testing, the regression analysis found no significant
change in chlamydia testing or diagnosis following train-
ing (testing Incident Rate Ratio (IRR) 1.01 95 % confi-
dence interval (CI) 0.96–1.07, P = 0.72; diagnosis IRR
0.98 (0.84–1.15), P = 0.84). However, the intervention
increased testing significantly in practices that received
specific payments for testing before the pilot began (IRR
2.12 (1.41–3.18), P < 0.001). A statistically significant
effect was seen when the number of GPs employed by
the practice was included as an effect modifier with prac-
tices employing between 6 and 15 GPs seeing significant
increases (6–10 GPs IRR 1.35 (1.07–1.71), P = 0.012; 11–
15 GPs IRR 1.37 (1.09–1.73), P = 0.007). A near significant
increase in testing was observed in practices with a lower
than English median testing rate prior to the intervention
(IRR 1.54 (0.99–2.37), P = 0.051), practices that did not get
paid for testing prior to the intervention (IRR 1.54 (0.99–
2.37), P = 0.051) and practices with ≥16 GPs employed
(IRR 1.27 (0.99–1.61), P = 0.053) (Table 2).
The per-protocol analysis model found the same
overall result as the intention-to-treat analysis, except no
difference was found in intervention effect between
practice sub-groups (see Additional file 1 for full results
plus analysis of practices that received training in phase
randomised to). The sub-group analyses in men and
women found no evidence to suggest any difference of
effect between these groups.
Discussion
Summary
This large national pilot found no major impact on chla-
mydia testing and diagnosis rates in participating general
practices following implementation of 3Cs&HIV training
despite staff reporting that they perceived the training as
useful and that it had increased their likelihood of
offering this service. There was evidence that the
Fig. 2 3Cs&HIV pilot step-wedge design indicating the control and intervention periods used for the analysis
Table 1 Characteristics of practices participating in the 3Cs &
HIV pilot
Intention-to-treat
N = 460 (%)
Per-protocol
N = 268 (%)
Chlamydia testing rate below England
median (<2.6 per 100)
163 (35.4) 183 (68.3)
Proximity to GUM clinic
Within 5 km 209 (45.4) 120 (44.8)
5-10 km 117 (32.0) 63 (23.5)
Further than 10 km 134 (29.1) 85 (31.7)
Practice IMDa group
1 (most deprived) 75 (16.3) 40 (14.9)
2 85 (18.5) 51 (19.0)
3 112 (24.3) 60 (22.4)
4 87 (18.9) 51 (19.0)
5 (least deprived) 98 (21.3) 66 (24.6)
Unknown 3 (0.7) 0 (0.0)
Rural location 27 (5.9) 21 (7.8)
Urban location 433 (94.1) 247 (92.2)
Number of GPs employed
1 12 (2.6) 6 (2.2)
2-5 130 (28.2) 74 (27.6)
6-10 158 (34.3) 98 (36.6)
11-15 108 (23.5) 58 (21.6)
16+ 52 (11.3) 32 (11.9)
Number of nurses employed
2-5 283 (61.5)) 164 (61.2)
6-10 111 (24.1) 69 (25.8)
11-15 9 (2.0) 7 (2.6)
Unknown 57 (12.4) 28 (10.5)
Financial incentive for testing in
place before training
No 43 (9.3) 39 (14.6)
Yes 148 (32.2) 132 (49.2)
Unknown 269 (58.5) 97 (36.2)
aIndices of multiple deprivations
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intervention increased testing in certain sub-groups,
these being practices with financial payments already in
place or with between 6 and 15 GPs. This indicates that
there are remaining barriers preventing intentions to test
being converted into actual tests submitted, and demon-
strates the importance of fully piloting and evaluating
any service improvement intervention to assess the im-
pact before widespread implementation. Our qualitative
work with GP staff who were involved in the workshops
(reported separately), suggests that the intervention may
not have been implemented exactly as intended. This
indicates the need for developing detailed understanding
of local services, and resources in order to select effect-
ive interventions.
The impact of this pilot differ from the intervention it
was based on, CIRT, possibly due to several factors;
changing context of the health care system with increas-
ing pressures on GP staff since the original CIRT study;
because the intervention was implemented in different
parts of the country; or increased complexity from the ori-
ginal intervention in part due to the additional elements
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Fig. 4 Median tests per practice per month split by phase of training started
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that each key message may have been diluted or been per-
ceived by GP staff as too onerous.
Strengths and limitations
The major strengths of this evaluation, unlike a cluster ran-
domised controlled trial within a research setting, are: the
large number of LAs with an opportunity to be involved,
the ability to ascertain the acceptance rate of the interven-
tion by LAs and take-up rate of training by practices across
a large sector of a country, and the ability to robustly
evaluate the implementation of an intervention with a
priori evidence of efficacy.
Evaluation of the pilot was limited by data availability;
this may have restricted the ability to identify further
factors which influenced effectiveness. Data on which
parts of the complex intervention were implemented,
the number of trainers per LA or detailed sexual health
training experience of trainer were absent. Missing data
for 28 practices may also explain why the sub-group
impact identified in the ITT analysis was not found
in the PP analysis, as these practices were not
included in the PP analysis. We could not determine
the number of offers of chlamydia tests by general
practice staff, which was also a limitation of other
general practice studies [25]. The analysis was limited
by the quality of surveillance data to measure tests
and diagnoses per practice. We could not determine
the tests and diagnoses by individual staff attending
training, only per practice. Allowing practices to
change the phase they are randomised to for training
has the potential to introduce bias, as they represent
a motivated group. It’s unclear what the direction of
this bias would be as high screening practices saw
minimal effect. The lack of sub-group impact found
in the ITT analysis in the PP analysis may be due to
missing data from practices that were not included
Comparison with existing literature & implications for
further research
Although not effective for all practices, testing did increase
in practices with existing financial incentives. Combining
financial rewards with educational training has proven
effective in other countries [26]. However, in England, edu-
cation and peer support have proven more effective than
financial incentives alone [34]. The 3Cs&HIV has shown
that practices with existing financial incentives are more
susceptible to training interventions than those who have
none. It is important to recognise that the 3Cs&HIV train-
ing did not introduce any new funding for testing and only
sought to remind practices of incentives already in place.
Following CIRT, and in line with other interventions
[25], 3Cs&HIV training emphasises the inclusion of all
general practice staff in training [20, 35]. The intervention
effect differed depending on the number of GPs employed
but not nurses. The difference between the number of
GPs having an effect and the number of nurses could be a
measure of how influential GPs are within a practice.
Alternatively higher GP numbers could be a marker of
sufficient capacity for each practitioner to follow their
special interest such as sexual health, or increased time
for staff for public health interventions.
Testing increased to near significant levels in practices
doing very little or no chlamydia testing prior to the
intervention, suggesting 3Cs&HIV training could be
used as a starter programme alongside more intensive
training programmes for practices that have limited
screening [36]. The absence of effect in practices with
above average testing rates prior to the intervention may
reflect interested practices taking up the training but
who already test at full capacity.
Despite the significant increases seen in testing rates
in some sub-groups, it’s important to recognise that the
number of tests and diagnoses per practice is still low
following training and these increases will not have a
widespread impact on national chlamydia testing rates
or detection rates to meet the Public Health Outcomes
Framework indicator of 2,300 diagnoses per 100,000 15
to 24 year olds in each LA [37].
This evaluation shows the difficulties in maintaining
practice engagement with sexual health training even with
those who have identified this as a training need and
volunteered to take part, as demonstrated by high practice
drop-out through the course of the pilot. Trainers
Table 2 Intention-to-treat analysis (460 practices) with adjusted






Adjusted incident rate ratio
(95 % confidence interval; P value)
Chlamydia testing rate
per practice in 2013
Less than England
median
163 1.54 (0.99-2.37; 0.051)
Greater than
England median
297 1.05 (0.69-1.60; 0.823)
Payment for chlamydia
screening
Yes 148 2.12 (1.41-3.18; <0.001)
No 43 1.54 (0.99-2.37; 0.051)
Unknown 269 1.77 (1.19-2.65; 0.005)
Number of GPs
employed
1 12 1.54 (0.99-2.37; 0.051)
2-5 130 1.19 (0.94-1.51; 0.156)
6-10 158 1.35 (1.07-1.71; 0.012)
11-15 108 1.37 (1.09-1.73; 0.007)
16+ 52 1.27 (0.99-1.61; 0.053)
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commonly found arranging sessions with practices time
consuming. General practice drop out of pilots or studies
is not uncommon and has been identified in other recent
studies in England [38–40]. Future primary care studies
should carefully identify which stakeholders influence
service provision in general practices and engage with
these organisations early on. This pilot worked with LAs
as they are responsible for commissioning public health
services from primary care. However, engagement with
the Local Medical Committee and Clinical Commission-
ing Group may be equally as important.
Conclusions
3Cs&HIV training is just one method aimed at improving
sexual health services in primary care. Improving chlamydia
testing provision in general practices remains important.
Over 70 % of young people attend their general practice in
a year and evidence suggests that young people want practi-
tioners and professionals to offer chlamydia testing rather
than them having to ask for it [6, 9]. Other methods for
general practice engagement to convert intention to test
into actual increased testing rates should continue to be
explored and rigorously evaluated with local support before
being endorsed by public health bodies.
Based on these findings, the authors do not endorse
adoption of the current 3Cs&HIV training as delivered
in this study, as a method of increasing chlamydia
screening or detection rates. The decision to use the
3Cs&HIV training materials needs to be made locally;
local teams should take into consideration the specific
practices in their area, the resources available to them to
ensure training is completed as intended, and how
screening in general practice fits with wider strategies.
Additional file
Additional file 1: Contains the per-protocol analysis for the 268
practices that received at least one training session. (DOC 37 kb)
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